Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Schutzer, William E ^a,b   Reed, John F ^a   Mader, Scott L ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

adrenergic; Aging; Aorta; Blood vessel; Caveolae; Hypertension

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CAVEOLIN 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2;

ADOLESCENT; AGING; ANIMAL TISSUE; AORTA; ARTICLE; CONFOCAL MICROSCOPY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR DOWN REGULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

AGING; ANIMALS; AORTA; BETA-ADRENERGIC RECEPTOR KINASE; CAVEOLIN 1; CAVEOLINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED F344; RECEPTORS, ADRENERGIC, BETA; VASODILATION;

EID: 18044387220     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01090.2004     Document Type: Article

References (39)

1. Anderson RGW. The caveolin membrane system. Annu Rev Biochem 67: 199-225, 1998.
2. Bakircioglu ME, Sievert KD, Nunes L, Lau A, Lin CS, and Lue TF. Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol 166: 734-738, 2001.
3. Carman CV, Lisanti MP, and Benovic JL. Regulation of G-protein receptor kinases by caveolin. J Biol Chem 274: 8858-8864, 1999.
4. Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, Mumby SM, Gilman AG, and Anderson RGW. Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126: 127-138, 1994.
5. Chapman J, Schutzer WE, Watts VJ, and Mader SL. Impaired cholera toxin relaxation with age in rat aorta. J Gerontol A Biol Sci Med Sci 54: B154-B159, 1999.
6. De Luca A, Sargiacomo M, Puca A, Sgaramella G, De Paolis P, Frati G, Morisco C, Trimarco B, Volpe M, and Condorelli G. Characterization of caveolae from rat heart: localization of postreceptor signal transduction molecules and their rearrangement after norepinephrine stimulation. J Cell Biochem 77: 529-539, 2000.
7. Deisher TA, Mankani S, and Hoffman BB. Role of cyclic AMP-dependent protein kinase in the diminished β-adrenergic responsiveness of vascular smooth muscle with increasing age. J Pharmacol Exp Ther 249: 812-819, 1989.
8. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, and Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
9. Gaballa MA, Eckhart AD, Koch WJ, and Goldman S. Vascular β-adrenergic receptor adenylyl cyclase system in maturation and aging. J Mol Cell Cardiol 32: 1745-1755, 2000.
10. Gurdal H, Friedman E, and Johnson M. β-Adrenoceptor-Gαs coupling decreases with age in rat aorta. Mol Pharmacol 47: 772-778, 1995.
11. Je HD, Gallant C, Leavis PC, and Morgan KG. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286: H91-H98, 2004.
12. Johnson MD, Zhou Y, Friedman E, and Roberts J. Expression of G-protein-α subunits in the aging cardiovascular system. J Gerontol Biol Sci 50A: B14-B19, 1995.
13. Kawabe J, Grant BS, Yamamoto M, Schwencke C, Okumura S, and Ishikawa Y. Changes in caveolin subtype protein expression in aging rat organs. Mol Cell Endocrinol 176: 91-95, 2001.
14. Li S, Couet J, and Lisanti MP. Src tyrosine kinases, Gα subunits, and H-ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996.
15. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, and Lisanti MP. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270: 15693-15701, 1995.
16. Mader SL and Alley PA. Age-related changes in adenylyl cyclase activity in rat aorta membranes. Mech Ageing Dev 101: 111-118, 1998.
17. Mader SL, Downing CL, Amos-Landgraf J, and Swebjka P. Age-related changes in G proteins in rat aorta. J Gerontol A Biol Sci Med Sci 51: B111-B116, 1996.
18. Minshall RD, Sessa WC, Stan RV, Anderson RG, and Malik AB. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285: L1179-L1183, 2003.
19. Oka N, Asai K, Kudej RK, Edwards JG, Toya Y, Schwencke C, Vatner DE, Vatner SF, and Ishikawa Y. Downregulation of caveolin by chronic β-adrenergic receptor stimulation in mice. Am J Physiol Cell Physiol 273: C1957-C1962, 1997.
20. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
21. Ostrom RS, Bundey RA, and Insel PA. Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes. J Biol Chem 279: 19846-19853, 2004.
22. Ostrom RS and Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143: 235-245, 2004.
23. Ostrom RS, Violin JD, Coleman S, and Insel PA. Selective enhancement of β-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 57: 1075-1079, 2000.
24. Pitcher JA, Freedman NJ, and Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem 67: 653-692, 1998.
25. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Knietz B, Lagaud G, Christ GJ, Edelmann W, and Lisanti MP. Caveolin-1 null mice are viable, but show evidence of hyper-proliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
26. Razani B, Woodman SE, and Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
27. Rybin VO, Xu X, Lisanti MP, and Steinberg SF. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275: 41447-41457, 2000.
28. Schutzer WE and Mader SL. Age-related changes in adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev 2: 169-190, 2003.
29. Schutzer WE, Reed JF, Bliziotes M, and Mader SL. Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. Am J Physiol Regul Integr Comp Physiol 280: R897-R903, 2001.
30. Schutzer WE, Watts VJ, Chapman J, Cumbay MG, Neve KA, Neve RL, and Mader SL. Viral-mediated gene delivery of constitutively activated Gαs alters vasoreactivity. Clin Exp Pharmacol Physiol 27: 9-13, 2000.
31. Schwencke C, Okumura S, Yamamoto M, Geng YJ, and Ishikawa Y. Colocalization of β-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem 75: 64-72, 1999.
32. Schwencke C, Yamamoto M, Okumura S, Toya Y, Kim SJ, and Ishikawa Y. Compartmentation of cyclic adenosine 3′,5′-monophosphate signaling in caveolae. Mol Endocrinol 13: 1061-1070, 1999.
33. Smirnov VN, Voyno-Yasenetskaya TA, Antonov AS, Lukashev ME, Shirinsky VP, Tertov VV, and Tkachuk VA. Vascular signal transduction and atherosclerosis. Ann NY Acad Sci 598: 167-181, 1990.
34. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, and Lisanti MP. Copurification and direct interaction of ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996.
35. Streeten DH and Anderson GH Jr. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens 9: 760-769, 1996.
36. Toya Y, Schwencke C, Couet J, Lisanti MP, and Ishikawa Y. Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 139: 2025-2031, 1998.
37. Tsujimoto G, Lee CH, and Hoffman BB. Age-related decrease in β-adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther 239: 411-415, 1986.
38. Tumer N, Scarpace PJ, and Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol 32: 271-302, 1992.
39. Wiener J, Loud AV, Giacomelli F, and Anversa P. Morphometric analysis of hypertension-induced hypertrophy of rat thoracic aorta. Am J Pathol 88: 619-633, 1977.